Inactive Instrument

Other languages Genmab Nasdaq Copenhagen

Equities

AVIS D'ANALYSTES DU JOUR : BNP Paribas, Renault, Pernod-Ricard, Eurofins, Ferrari, Worldline, Sika, Elior...	04/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Burberry, Endesa, Ferrari, Genmab, Melia Hotels, Telefónica, Sika..	04/04
Genmab : l'acquisition de ProfoundBio accueillie sans émotion	03/04
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	03/04
Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio	03/04
Denmark's Genmab to acquire ProfoundBio for $1.8 billion	03/04
Bolsa de Madrid: Después de Semana Santa, algo va mal	03/04
Genmab to Acquire ProfoundBio for $1.8 Billion	03/04
Après Pâques, un truc qui cloche	03/04
En Direct des Marchés : Thales, Renault, Eurofins, Virbac, Atos, Clariant, Sika, Genmab...	03/04
Genmab to Purchase US-based ProfoundBio for $1.8 Billion	03/04
Genmab neemt ProfoundBio over	03/04
EN DIRECTO DESDE LOS MERCADOS: Repsol, Naturgy, Siemens, Intel, General Motors, Sika, Xiaomi, Kering...	03/04
Genmab A/S commences an Equity Buyback Plan under the authorization approved on March 13, 2024.	25/03
Genmab Completes Share Buyback Program	18/03
Genmab to Repurchase Up to $511 Million Shares	15/03
Genmab A/S Announces Executive Changes	14/03
Genmab Seeks M&A Opportunities	13/03
UK Spring Budget Cheer Buoys Swiss Stocks	06/03
GENMAB : Genmab is available at a bargain price	04/03

No results for this search

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 04:40 pm IST